The role of self-efficacy in inflammatory bowel disease management: Preliminary validation of a disease-specific measure

Inflammatory Bowel Diseases

Volumn 17, Issue 2, 2011, Pages 614-620

  Keefer, Laurie ^a   Kiebles, Jennifer L ^a   Taft, Tiffany H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

disease management; IBD; IBD Self Efficacy Scale; self efficacy

Indexed keywords

ADULT; AGED; ARTICLE; BRIEF SYMPTOM INVENTORY; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; CROHN DISEASE; DISEASE COURSE; DISTRESS SYNDROME; EMOTION; ENTERITIS; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE SELF EFFICACY SCALE; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PERCEIVED HEALTH COMPETENCE SCALE; PERCEIVED STRESS QUESTIONNAIRE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; REMISSION; ROSENBERG SELF ESTEEM SCALE; SELF CONCEPT; SHORT FORM 12; STRUCTURED QUESTIONNAIRE; TEST RETEST RELIABILITY; ULCERATIVE COLITIS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SELF CARE; SELF EFFICACY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651335179     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21314     Document Type: Article

References (35)

1. Larsson K, Loof L, Ronnblom A, Nordin K,. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008; 64: 139-148.
2. van den lejk L, Vlachonikolis IG, Munkholm P, et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004; 10: 392-398.
3. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 2002: 450-457.
4. Jones M, Wessinger S, Crowell MD,. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006; 4: 474-481.
5. Kane S, Cohen RD, Aikens JE, Hanauer SB,: Predictors of non-compliance with mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001; 96: 2929-2932.
6. Kane S HD, Kalyani M,: A pilot feasbility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol. 2003; 1: 170-173.
7. Sewitch M, Abrahamowicz, M, Barkun A, et al. Patient non-adherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003; 98: 1535-1544.
8. Shale M, Riley SA,. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Therapeut. 2003; 18: 191-203.
9. Sternberg S, Chrousos GP, Wilder RL, Gold PW,. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992; 117: 854-866.
10. vonWietersheim J, Kohler T, Feiereis H,. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom. 1992; 58: 103-112.
11. Barry LC, Guo Z, Kerns RD, et al. Functional self-efficacy and pain-related disability among older veterans with chronic pain in a primary care setting. Pain. 2003; 104: 131-137.
12. Cross MJ, March LM, Lapsley HM, et al. Patient self-efficacy and health locus of control: Relationships with health status and arthritis-related expenditure. Rheumatology (Oxford). 2006; 45: 92-96.
13. Findley JC, Kerns R, Weinberg LD, Rosenberg R,. Self-efficacy as a psychological moderator of chronic fatigue syndrome. J Behav Med. 1998; 21: 351-362.
14. Saunders D,. Coping with chronic pain: what can we learn from pain self-efficacy beliefs? J Rheumatol. 2004; 31: 1032-1034.
15. Schiaffino KM, Revenson TA, Gibofsky A,. Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis. Arthritis Care Res. 1991; 4: 150-157.
16. Bandura A,. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84: 191-215.
17. Bandura A,. Self-Efficacy: The Exercise of Self-Control. New York: WH Freeman; 1997.
18. Hoffman A, vonEye A, Gift AG, et al. Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. Nurs Res. 2009; 58: 32-41.
19. Airlie J, Baker GA, Smith SJ, Young CA,. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clin Rehabil. 2001; 15: 259-265.
20. Sarkar U, Ali S, Whooley MA,. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the heart and soul study. Health Psychol. 2009; 28: 166-173.
21. Bernal H, Woolley S, Schenaul J, Dickinson J,. Correlates of self-efficacy in diabetes self-care among Hispanic adults with diabetes. Diabetes Educ. 2000; 26: 673-680.
22. McAuley E, Lox C, Duncan TE,. Long-term maintenance of exercise, self-efficacy and physiological change in older adults. J Gerontol. 1993; 48: 218-224.
23. Fernandez M, Diamond, PM, Rakowski W, et al. Development and validation of a cervical cancer screening self-efficacy scale for low-income Mexican American women. Cancer Epidemiol Biomarkers Prev. 2009; 18: 866-875.
24. Steffen A, McKibbin C, Zeiss AM, et al. The revised scale for caregiving self-efficacy: Reliability and validity studies. J Gerontol. 2002; 57B: 74-86.
25. Irvine E,: Development and subsequent refinement of the inflammatory bowel disease questionnaire: A quality of life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1999; 28: S23-27.
26. Rosenberg M,. Rosenberg Self Esteem Scale. Princeton, NJ: Princeton University Press; 1965.
27. Derogatis LR, and, Melisaratos, N.,: The brief symptom inventory: An introductory report. Psychol Med. 1983; 13: 595-605.
28. Smith M, Wallston K, Smith C,. The development and validation of the perceived health competence scale. Health Educ Res. 1995; 10: 51-64.
29. Levenstein S, Prantera C, Varvo V, et al. Development of the perceived stress questionnaire: A new tool for psychosomatic research. J Psychosom Res. 1993; 37: 19-32.
30. Ware JE, Kosinski, M., et al. Version 2 of the SF-12 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2002.
31. Ware JE,. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center; 1993.
32. Drossman DA, Leserman J, Mitchell CM,. Health status and health care use in persons with inflammatory bowel disease: A national sample. Dig Dis Sci. 1991; 36: 1746-1755.
33. Meyers S, Janowitz, HD,. Natural history of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology. 1984; 87: 1189-1192.
34. Drossman DA, Leserman J, Li Z,. The rating form of ibd patient concerns: A new measure of health status. Psychosom Med. 1991; 53: 701-712.
35. Jones M, Bratten J, Keefer L,. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. Am J Gastroenterol. 2007; 102: 2232-2237.